DE1903050A1 - Verfahren zur Feststellung und Lokalisation von neoplastischem Zellmaterial - Google Patents

Verfahren zur Feststellung und Lokalisation von neoplastischem Zellmaterial

Info

Publication number
DE1903050A1
DE1903050A1 DE19691903050 DE1903050A DE1903050A1 DE 1903050 A1 DE1903050 A1 DE 1903050A1 DE 19691903050 DE19691903050 DE 19691903050 DE 1903050 A DE1903050 A DE 1903050A DE 1903050 A1 DE1903050 A1 DE 1903050A1
Authority
DE
Germany
Prior art keywords
cells
glycoprotein
neoplastic
cell
marked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691903050
Other languages
German (de)
English (en)
Inventor
Burger Max Marcel
Goldberg Allan Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BURGER MAX MARCEL
GOLDBERG ALLAN ROY
Original Assignee
BURGER MAX MARCEL
GOLDBERG ALLAN ROY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BURGER MAX MARCEL, GOLDBERG ALLAN ROY filed Critical BURGER MAX MARCEL
Publication of DE1903050A1 publication Critical patent/DE1903050A1/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19691903050 1968-01-24 1969-01-22 Verfahren zur Feststellung und Lokalisation von neoplastischem Zellmaterial Pending DE1903050A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70001668A 1968-01-24 1968-01-24
US78568868A 1968-12-20 1968-12-20

Publications (1)

Publication Number Publication Date
DE1903050A1 true DE1903050A1 (de) 1969-09-25

Family

ID=27106537

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691903050 Pending DE1903050A1 (de) 1968-01-24 1969-01-22 Verfahren zur Feststellung und Lokalisation von neoplastischem Zellmaterial

Country Status (10)

Country Link
BE (1) BE727413A (da)
CA (1) CA918638A (da)
CH (1) CH521749A (da)
DE (1) DE1903050A1 (da)
DK (1) DK125655B (da)
ES (1) ES362780A1 (da)
FR (1) FR2000654A1 (da)
GB (1) GB1260711A (da)
IL (1) IL31469A0 (da)
NL (1) NL6901134A (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214A1 (en) * 1978-07-07 1980-01-23 Samuel Dr. Bogoch Product for detecting the presence of cancerous or malignant tumor cells

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527196B2 (en) * 1979-04-16 1983-02-17 Massachusetts Institute Of Technology Enzymatic method for detecting cancer in mammalian tissue
EP2979093B1 (en) * 2013-03-29 2019-10-23 Siemens Healthcare Diagnostics Inc. Rare cell concentration

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214A1 (en) * 1978-07-07 1980-01-23 Samuel Dr. Bogoch Product for detecting the presence of cancerous or malignant tumor cells

Also Published As

Publication number Publication date
NL6901134A (da) 1969-07-28
CA918638A (en) 1973-01-09
CH521749A (de) 1972-04-30
BE727413A (da) 1969-07-24
GB1260711A (en) 1972-01-19
ES362780A1 (es) 1971-02-16
IL31469A0 (en) 1969-11-12
FR2000654A1 (da) 1969-09-12
DK125655B (da) 1973-03-19

Similar Documents

Publication Publication Date Title
DE3109252C2 (de) Verfahren und Zusammensetzung zur Bestimmung einzelner Leukozyten durch metachromatische Farbstoffdifferentialabsorption
DE60104392T2 (de) Verfahren zum nachweis der effektivität einer krebstherapie
DE68927479T2 (de) Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
DE2029499C3 (de) Verfahren zum Nachweis der Anwesenheit von carcinoembryonalen Antigenen im Blut
CH648330A5 (de) Tumor-spezifische glykoproteine und verfahren zu deren herstellung.
DE2648458C2 (de) Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens
DE3752007T2 (de) Mittel zur Entziehung von Endprodukten der fortgeschrittenen Glycosylation
DE69022819T2 (de) Verbindungen und Reagenzien zur Bestimmung von Retikulozyten.
DE60217351T2 (de) Verfahren zur Proben-Identifizierung bei einem Säugetier sowie ein Kit zur Durchführung dieses Verfahrens
von Bertalanffy Acridine orange fluorescence in cell physiology, cytochemistry and medicine
DE2628468C2 (de) Verfahren zur Färbung von Basophilen und Reagens zur Durchführung dieses Verfahrens
DE2745237A1 (de) Mittel zur immunisierung und zum nachweis von speziellen krebsarten
EP0107045A1 (de) Verfahren zur Gewinnung von Relaxin aus Milch
DE2635065A1 (de) Verfahren zur halbkontinuierlichen behandlung von gesamtblut
DE1903050A1 (de) Verfahren zur Feststellung und Lokalisation von neoplastischem Zellmaterial
DE69321454T2 (de) Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit
AT293611B (de) Verfahren zur Feststellung von neoplastischem Zellmaterial
DE2333740C2 (de) Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs
HH et al. Discussion on tuberculins in human and veterinary medicine.
DE2606257A1 (de) Recognine
DE2546670A1 (de) Recognine
EP1188055B1 (de) Labormässige untersuchung einer körperflüssigkeits- oder gewebeprobe
US5952192A (en) Method of fluorescent analysis of biological sample utilizing biebrich scarlet
DE2205897C3 (de) Verfahren zur Herstellung von Antithymozytenserum
DD139903A5 (de) Testverfahren zur diagnose von malignomen